Research Institute of Influenza, Russia   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Saint Petersburg Russian Federation (1967)

Organization Overview

First Clinical Trial
2009
NCT04682444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Research Institute of Influenza, Russia | Research Institute of Influenza, Sankt-Peterburg, Russian Federation | Smorodintsev Research Institute of Influenza

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Influenza, Human (Phase 3)

Influenza in Birds (Phase 1)

Tuberculosis (Phase 1)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 8